Xeomin 50 LD50-Einheiten

Xeomin 50 LD50-Einheiten is a medicine authorised by Swissmedic under authorisation number 62080. The authorisation holder is Merz Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 April 2013 and the authorisation is valid without a time limit. ATC code M03AX01 places the medicine in the group Muscle relaxants.

  • Dispensing category A
  • Authorisation number 62080
  • ATC M03AX01
  • Biotechnological medicines
Authorisation data
Authorisation number62080
NameXeomin 50 LD50-Einheiten
Full nameXeomin 50 LD50-Einheiten, Pulver zur Herstellung einer Injektionslösung
Authorisation holderMerz Pharma (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeM03AX01
First authorisation12 April 2013
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Xeomin 50 LD50-Einheiten, Pulver zur Herstellung einer InjektionslösungA12 April 2013
2Xeomin 100 LD50-Einheiten, Pulver zur Herstellung einer InjektionslösungA12 April 2013
3Xeomin 200 LD50-Einheiten, Pulver zur Herstellung einer InjektionslösungA24 August 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)M03AX0101.13.0.A
21Durchstechflasche(n)M03AX0101.13.0.A
31Durchstechflasche(n)M03AX0101.13.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Xeomin 50 LD50-Einheiten authorised in Switzerland?

Yes. Xeomin 50 LD50-Einheiten is authorised by Swissmedic under authorisation number 62080, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Xeomin 50 LD50-Einheiten have?

Xeomin 50 LD50-Einheiten is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Xeomin 50 LD50-Einheiten?

The authorisation holder is Merz Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com